{"id": "study_Study 10", "study": "Study 10", "type": "study_summary", "total_subjects": 59, "total_issues": 147, "document": "# Study Summary: Study 10\n\n## Overview\n- **Total Subjects**: 59\n- **Countries**: 7 (USA, ITA, CHN, JPN, HUN...)\n- **Sites**: 27\n- **Total Issues Identified**: 147\n\n## Risk Distribution\n- **Low Risk**: 19 subjects (32.2%)\n- **Medium Risk**: 36 subjects (61.0%)\n- **High Risk**: 3 subjects (5.1%)\n- **Critical Risk**: 1 subjects (1.7%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 3\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 70\n- **Outstanding Visits**: 6\n\n## Pending Items\n- **Subjects with Pending Items**: 15 (25.4%)\n\n## Key Metrics\n- **Average Issues per Subject**: 2.49\n- **Clean Subjects (No Issues)**: 19 (32.2%)\n\n## Priority Subjects Requiring Attention\n- Subject 3509\n- Subject 3517\n- Subject 3521\n- Subject 587\n\n## CRA Recommendations\n1. Focus monitoring efforts on 4 high/critical risk subjects\n2. Resolve 3 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 70 missing data points\n5. Schedule reviews for 6 overdue visits\n"}
{"id": "study_Study 11", "study": "Study 11", "type": "study_summary", "total_subjects": 41, "total_issues": 21, "document": "# Study Summary: Study 11\n\n## Overview\n- **Total Subjects**: 41\n- **Countries**: 19 (NLD, JPN, CHE, CZE, GBR...)\n- **Sites**: 35\n- **Total Issues Identified**: 21\n\n## Risk Distribution\n- **Low Risk**: 28 subjects (68.3%)\n- **Medium Risk**: 13 subjects (31.7%)\n- **High Risk**: 0 subjects (0.0%)\n- **Critical Risk**: 0 subjects (0.0%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 1\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 16\n- **Outstanding Visits**: 0\n\n## Pending Items\n- **Subjects with Pending Items**: 3 (7.3%)\n\n## Key Metrics\n- **Average Issues per Subject**: 0.51\n- **Clean Subjects (No Issues)**: 28 (68.3%)\n\n## Priority Subjects Requiring Attention\nNo high-risk subjects identified.\n\n## CRA Recommendations\n1. Focus monitoring efforts on 0 high/critical risk subjects\n2. Resolve 1 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 16 missing data points\n5. Schedule reviews for 0 overdue visits\n"}
{"id": "study_Study 13", "study": "Study 13", "type": "study_summary", "total_subjects": 20, "total_issues": 36, "document": "# Study Summary: Study 13\n\n## Overview\n- **Total Subjects**: 20\n- **Countries**: 8 (KOR, SGP, TWN, CAN, JPN...)\n- **Sites**: 11\n- **Total Issues Identified**: 36\n\n## Risk Distribution\n- **Low Risk**: 11 subjects (55.0%)\n- **Medium Risk**: 8 subjects (40.0%)\n- **High Risk**: 0 subjects (0.0%)\n- **Critical Risk**: 1 subjects (5.0%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 3\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 23\n- **Outstanding Visits**: 0\n\n## Pending Items\n- **Subjects with Pending Items**: 6 (30.0%)\n\n## Key Metrics\n- **Average Issues per Subject**: 1.80\n- **Clean Subjects (No Issues)**: 11 (55.0%)\n\n## Priority Subjects Requiring Attention\n- Subject 893\n\n## CRA Recommendations\n1. Focus monitoring efforts on 1 high/critical risk subjects\n2. Resolve 3 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 23 missing data points\n5. Schedule reviews for 0 overdue visits\n"}
{"id": "study_Study 14", "study": "Study 14", "type": "study_summary", "total_subjects": 3, "total_issues": 0, "document": "# Study Summary: Study 14\n\n## Overview\n- **Total Subjects**: 3\n- **Countries**: 1 (CAN)\n- **Sites**: 2\n- **Total Issues Identified**: 0\n\n## Risk Distribution\n- **Low Risk**: 3 subjects (100.0%)\n- **Medium Risk**: 0 subjects (0.0%)\n- **High Risk**: 0 subjects (0.0%)\n- **Critical Risk**: 0 subjects (0.0%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 0\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 0\n- **Outstanding Visits**: 0\n\n## Pending Items\n- **Subjects with Pending Items**: 0 (0.0%)\n\n## Key Metrics\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects (No Issues)**: 3 (100.0%)\n\n## Priority Subjects Requiring Attention\nNo high-risk subjects identified.\n\n## CRA Recommendations\n1. Focus monitoring efforts on 0 high/critical risk subjects\n2. Resolve 0 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 0 missing data points\n5. Schedule reviews for 0 overdue visits\n"}
{"id": "study_Study 15", "study": "Study 15", "type": "study_summary", "total_subjects": 55, "total_issues": 1, "document": "# Study Summary: Study 15\n\n## Overview\n- **Total Subjects**: 55\n- **Countries**: 1 (USA)\n- **Sites**: 2\n- **Total Issues Identified**: 1\n\n## Risk Distribution\n- **Low Risk**: 54 subjects (98.2%)\n- **Medium Risk**: 1 subjects (1.8%)\n- **High Risk**: 0 subjects (0.0%)\n- **Critical Risk**: 0 subjects (0.0%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 0\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 0\n- **Outstanding Visits**: 0\n\n## Pending Items\n- **Subjects with Pending Items**: 1 (1.8%)\n\n## Key Metrics\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects (No Issues)**: 54 (98.2%)\n\n## Priority Subjects Requiring Attention\nNo high-risk subjects identified.\n\n## CRA Recommendations\n1. Focus monitoring efforts on 0 high/critical risk subjects\n2. Resolve 0 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 0 missing data points\n5. Schedule reviews for 0 overdue visits\n"}
{"id": "study_Study 16", "study": "Study 16", "type": "study_summary", "total_subjects": 672, "total_issues": 1383, "document": "# Study Summary: Study 16\n\n## Overview\n- **Total Subjects**: 672\n- **Countries**: 23 (USA, CAN, GRC, BEL, FRA...)\n- **Sites**: 176\n- **Total Issues Identified**: 1383\n\n## Risk Distribution\n- **Low Risk**: 435 subjects (64.7%)\n- **Medium Risk**: 141 subjects (21.0%)\n- **High Risk**: 85 subjects (12.6%)\n- **Critical Risk**: 11 subjects (1.6%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 1059\n- **Safety Discrepancies**: 44\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 221\n- **Outstanding Visits**: 327\n\n## Pending Items\n- **Subjects with Pending Items**: 190 (28.3%)\n\n## Key Metrics\n- **Average Issues per Subject**: 2.06\n- **Clean Subjects (No Issues)**: 435 (64.7%)\n\n## Priority Subjects Requiring Attention\n- All-metadata issue\n- Subject 4092\n- Subject 4108\n- Subject 4112\n- Subject 4153\n- Subject 4194\n- Subject 4195\n- Subject 4196\n- Subject 4197\n- Subject 4198\n\n## CRA Recommendations\n1. Focus monitoring efforts on 96 high/critical risk subjects\n2. Resolve 1059 open EDRR issues to improve data quality\n3. Address 44 safety discrepancies as priority\n4. Follow up on 221 missing data points\n5. Schedule reviews for 327 overdue visits\n"}
{"id": "study_Study 17", "study": "Study 17", "type": "study_summary", "total_subjects": 47, "total_issues": 298, "document": "# Study Summary: Study 17\n\n## Overview\n- **Total Subjects**: 47\n- **Countries**: 6 (ESP, USA, CAN, FRA, ISR...)\n- **Sites**: 13\n- **Total Issues Identified**: 298\n\n## Risk Distribution\n- **Low Risk**: 16 subjects (34.0%)\n- **Medium Risk**: 22 subjects (46.8%)\n- **High Risk**: 6 subjects (12.8%)\n- **Critical Risk**: 3 subjects (6.4%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 22\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 253\n- **Outstanding Visits**: 8\n\n## Pending Items\n- **Subjects with Pending Items**: 10 (21.3%)\n\n## Key Metrics\n- **Average Issues per Subject**: 6.34\n- **Clean Subjects (No Issues)**: 16 (34.0%)\n\n## Priority Subjects Requiring Attention\n- Subject 1595\n- Subject 25\n- Subject 2649\n- Subject 3544\n- Subject 3546\n- Subject 4756\n- Subject 4759\n- Subject 55\n- Subject 594\n\n## CRA Recommendations\n1. Focus monitoring efforts on 9 high/critical risk subjects\n2. Resolve 22 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 253 missing data points\n5. Schedule reviews for 8 overdue visits\n"}
{"id": "study_Study 18", "study": "Study 18", "type": "study_summary", "total_subjects": 164, "total_issues": 12, "document": "# Study Summary: Study 18\n\n## Overview\n- **Total Subjects**: 164\n- **Countries**: 1 (USA)\n- **Sites**: 2\n- **Total Issues Identified**: 12\n\n## Risk Distribution\n- **Low Risk**: 155 subjects (94.5%)\n- **Medium Risk**: 9 subjects (5.5%)\n- **High Risk**: 0 subjects (0.0%)\n- **Critical Risk**: 0 subjects (0.0%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 0\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 0\n- **Outstanding Visits**: 0\n\n## Pending Items\n- **Subjects with Pending Items**: 9 (5.5%)\n\n## Key Metrics\n- **Average Issues per Subject**: 0.07\n- **Clean Subjects (No Issues)**: 155 (94.5%)\n\n## Priority Subjects Requiring Attention\nNo high-risk subjects identified.\n\n## CRA Recommendations\n1. Focus monitoring efforts on 0 high/critical risk subjects\n2. Resolve 0 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 0 missing data points\n5. Schedule reviews for 0 overdue visits\n"}
{"id": "study_Study 19", "study": "Study 19", "type": "study_summary", "total_subjects": 44, "total_issues": 196, "document": "# Study Summary: Study 19\n\n## Overview\n- **Total Subjects**: 44\n- **Countries**: 8 (TWN, KOR, FRA, AUS, ISR...)\n- **Sites**: 13\n- **Total Issues Identified**: 196\n\n## Risk Distribution\n- **Low Risk**: 22 subjects (50.0%)\n- **Medium Risk**: 19 subjects (43.2%)\n- **High Risk**: 1 subjects (2.3%)\n- **Critical Risk**: 2 subjects (4.5%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 0\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 171\n- **Outstanding Visits**: 15\n\n## Pending Items\n- **Subjects with Pending Items**: 30 (68.2%)\n\n## Key Metrics\n- **Average Issues per Subject**: 4.45\n- **Clean Subjects (No Issues)**: 22 (50.0%)\n\n## Priority Subjects Requiring Attention\n- Subject 4890\n- Subject 4895\n- Subject 912\n\n## CRA Recommendations\n1. Focus monitoring efforts on 3 high/critical risk subjects\n2. Resolve 0 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 171 missing data points\n5. Schedule reviews for 15 overdue visits\n"}
{"id": "study_Study 1", "study": "Study 1", "type": "study_summary", "total_subjects": 88, "total_issues": 1108, "document": "# Study Summary: Study 1\n\n## Overview\n- **Total Subjects**: 88\n- **Countries**: 10 (FRA, AUT, ISR, DEU, SGP...)\n- **Sites**: 24\n- **Total Issues Identified**: 1108\n\n## Risk Distribution\n- **Low Risk**: 40 subjects (45.5%)\n- **Medium Risk**: 15 subjects (17.0%)\n- **High Risk**: 9 subjects (10.2%)\n- **Critical Risk**: 24 subjects (27.3%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 61\n- **Safety Discrepancies**: 700\n- **Missing CRF Pages**: 193\n- **Missing Lab Records**: 128\n- **Outstanding Visits**: 15\n\n## Pending Items\n- **Subjects with Pending Items**: 33 (37.5%)\n\n## Key Metrics\n- **Average Issues per Subject**: 12.59\n- **Clean Subjects (No Issues)**: 40 (45.5%)\n\n## Priority Subjects Requiring Attention\n- Subject 10\n- Subject 12\n- Subject 14\n- Subject 18\n- Subject 19\n- Subject 22\n- Subject 32\n- Subject 36\n- Subject 39\n- Subject 42\n\n## CRA Recommendations\n1. Focus monitoring efforts on 33 high/critical risk subjects\n2. Resolve 61 open EDRR issues to improve data quality\n3. Address 700 safety discrepancies as priority\n4. Follow up on 321 missing data points\n5. Schedule reviews for 15 overdue visits\n"}
{"id": "study_Study 20", "study": "Study 20", "type": "study_summary", "total_subjects": 19, "total_issues": 98, "document": "# Study Summary: Study 20\n\n## Overview\n- **Total Subjects**: 19\n- **Countries**: 7 (NLD, FRA, SGP, KOR, AUS...)\n- **Sites**: 9\n- **Total Issues Identified**: 98\n\n## Risk Distribution\n- **Low Risk**: 14 subjects (73.7%)\n- **Medium Risk**: 1 subjects (5.3%)\n- **High Risk**: 2 subjects (10.5%)\n- **Critical Risk**: 2 subjects (10.5%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 0\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 82\n- **Outstanding Visits**: 0\n\n## Pending Items\n- **Subjects with Pending Items**: 2 (10.5%)\n\n## Key Metrics\n- **Average Issues per Subject**: 5.16\n- **Clean Subjects (No Issues)**: 14 (73.7%)\n\n## Priority Subjects Requiring Attention\n- Subject 2844\n- Subject 3544\n- Subject 4904\n- Subject 627\n\n## CRA Recommendations\n1. Focus monitoring efforts on 4 high/critical risk subjects\n2. Resolve 0 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 82 missing data points\n5. Schedule reviews for 0 overdue visits\n"}
{"id": "study_Study 21", "study": "Study 21", "type": "study_summary", "total_subjects": 20401, "total_issues": 229, "document": "# Study Summary: Study 21\n\n## Overview\n- **Total Subjects**: 20401\n- **Countries**: 49 (IND, ARG, EST, MUS, FRA...)\n- **Sites**: 1056\n- **Total Issues Identified**: 229\n\n## Risk Distribution\n- **Low Risk**: 20235 subjects (99.2%)\n- **Medium Risk**: 165 subjects (0.8%)\n- **High Risk**: 1 subjects (0.0%)\n- **Critical Risk**: 0 subjects (0.0%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 93\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 0\n- **Outstanding Visits**: 354\n\n## Pending Items\n- **Subjects with Pending Items**: 430 (2.1%)\n\n## Key Metrics\n- **Average Issues per Subject**: 0.01\n- **Clean Subjects (No Issues)**: 20235 (99.2%)\n\n## Priority Subjects Requiring Attention\n- Subject 28392\n\n## CRA Recommendations\n1. Focus monitoring efforts on 1 high/critical risk subjects\n2. Resolve 93 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 0 missing data points\n5. Schedule reviews for 354 overdue visits\n"}
{"id": "study_Study 22", "study": "Study 22", "type": "study_summary", "total_subjects": 648, "total_issues": 884, "document": "# Study Summary: Study 22\n\n## Overview\n- **Total Subjects**: 648\n- **Countries**: 39 (ARG, BGR, BRA, CAN, COL...)\n- **Sites**: 379\n- **Total Issues Identified**: 884\n\n## Risk Distribution\n- **Low Risk**: 102 subjects (15.7%)\n- **Medium Risk**: 531 subjects (81.9%)\n- **High Risk**: 11 subjects (1.7%)\n- **Critical Risk**: 4 subjects (0.6%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 277\n- **Safety Discrepancies**: 165\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 0\n- **Outstanding Visits**: 0\n\n## Pending Items\n- **Subjects with Pending Items**: 233 (36.0%)\n\n## Key Metrics\n- **Average Issues per Subject**: 1.36\n- **Clean Subjects (No Issues)**: 102 (15.7%)\n\n## Priority Subjects Requiring Attention\n- Subject 14997\n- Subject 15526\n- Subject 20819\n- Subject 30507\n- Subject 31000\n- Subject 31333\n- Subject 31338\n- Subject 31445\n- Subject 31555\n- Subject 31665\n\n## CRA Recommendations\n1. Focus monitoring efforts on 15 high/critical risk subjects\n2. Resolve 277 open EDRR issues to improve data quality\n3. Address 165 safety discrepancies as priority\n4. Follow up on 0 missing data points\n5. Schedule reviews for 0 overdue visits\n"}
{"id": "study_Study 23", "study": "Study 23", "type": "study_summary", "total_subjects": 1855, "total_issues": 460, "document": "# Study Summary: Study 23\n\n## Overview\n- **Total Subjects**: 1855\n- **Countries**: 13 (BFA, TZA, UGA, KEN, COD...)\n- **Sites**: 35\n- **Total Issues Identified**: 460\n\n## Risk Distribution\n- **Low Risk**: 1718 subjects (92.6%)\n- **Medium Risk**: 114 subjects (6.1%)\n- **High Risk**: 23 subjects (1.2%)\n- **Critical Risk**: 0 subjects (0.0%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 456\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 1\n- **Outstanding Visits**: 5\n\n## Pending Items\n- **Subjects with Pending Items**: 4 (0.2%)\n\n## Key Metrics\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects (No Issues)**: 1718 (92.6%)\n\n## Priority Subjects Requiring Attention\n- Subject 1081\n- Subject 4029\n- Subject 46051\n- Subject 46642\n- Subject 46912\n- Subject 46922\n- Subject 46935\n- Subject 46937\n- Subject 46949\n- Subject 46951\n\n## CRA Recommendations\n1. Focus monitoring efforts on 23 high/critical risk subjects\n2. Resolve 456 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 1 missing data points\n5. Schedule reviews for 5 overdue visits\n"}
{"id": "study_Study 24", "study": "Study 24", "type": "study_summary", "total_subjects": 530, "total_issues": 18698, "document": "# Study Summary: Study 24\n\n## Overview\n- **Total Subjects**: 530\n- **Countries**: 13 (AUS, TUR, CAN, MEX, USA...)\n- **Sites**: 103\n- **Total Issues Identified**: 18698\n\n## Risk Distribution\n- **Low Risk**: 16 subjects (3.0%)\n- **Medium Risk**: 96 subjects (18.1%)\n- **High Risk**: 103 subjects (19.4%)\n- **Critical Risk**: 315 subjects (59.4%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 27\n- **Safety Discrepancies**: 133\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 18103\n- **Outstanding Visits**: 78\n\n## Pending Items\n- **Subjects with Pending Items**: 238 (44.9%)\n\n## Key Metrics\n- **Average Issues per Subject**: 35.28\n- **Clean Subjects (No Issues)**: 16 (3.0%)\n\n## Priority Subjects Requiring Attention\n- Subject 1\n- Subject 107\n- Subject 108\n- Subject 11\n- Subject 12\n- Subject 13\n- Subject 13635\n- Subject 13651\n- Subject 13652\n- Subject 13655\n\n## CRA Recommendations\n1. Focus monitoring efforts on 418 high/critical risk subjects\n2. Resolve 27 open EDRR issues to improve data quality\n3. Address 133 safety discrepancies as priority\n4. Follow up on 18103 missing data points\n5. Schedule reviews for 78 overdue visits\n"}
{"id": "study_Study 25", "study": "Study 25", "type": "study_summary", "total_subjects": 1374, "total_issues": 270, "document": "# Study Summary: Study 25\n\n## Overview\n- **Total Subjects**: 1374\n- **Countries**: 36 (ARG, HUN, CAN, IND, USA...)\n- **Sites**: 225\n- **Total Issues Identified**: 270\n\n## Risk Distribution\n- **Low Risk**: 1255 subjects (91.3%)\n- **Medium Risk**: 105 subjects (7.6%)\n- **High Risk**: 13 subjects (0.9%)\n- **Critical Risk**: 1 subjects (0.1%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 48\n- **Safety Discrepancies**: 217\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 5\n- **Outstanding Visits**: 0\n\n## Pending Items\n- **Subjects with Pending Items**: 0 (0.0%)\n\n## Key Metrics\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects (No Issues)**: 1255 (91.3%)\n\n## Priority Subjects Requiring Attention\n- Subject 13659\n- Subject 1478\n- Subject 279\n- Subject 31086\n- Subject 31114\n- Subject 33012\n- Subject 448\n- Subject 47872\n- Subject 48196\n- Subject 4897\n\n## CRA Recommendations\n1. Focus monitoring efforts on 14 high/critical risk subjects\n2. Resolve 48 open EDRR issues to improve data quality\n3. Address 217 safety discrepancies as priority\n4. Follow up on 5 missing data points\n5. Schedule reviews for 0 overdue visits\n"}
{"id": "study_Study 2", "study": "Study 2", "type": "study_summary", "total_subjects": 79, "total_issues": 43, "document": "# Study Summary: Study 2\n\n## Overview\n- **Total Subjects**: 79\n- **Countries**: 1 (CHN)\n- **Sites**: 18\n- **Total Issues Identified**: 43\n\n## Risk Distribution\n- **Low Risk**: 75 subjects (94.9%)\n- **Medium Risk**: 2 subjects (2.5%)\n- **High Risk**: 1 subjects (1.3%)\n- **Critical Risk**: 1 subjects (1.3%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 1\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 42\n- **Outstanding Visits**: 2\n\n## Pending Items\n- **Subjects with Pending Items**: 2 (2.5%)\n\n## Key Metrics\n- **Average Issues per Subject**: 0.54\n- **Clean Subjects (No Issues)**: 75 (94.9%)\n\n## Priority Subjects Requiring Attention\n- Subject 102\n- Subject 130\n\n## CRA Recommendations\n1. Focus monitoring efforts on 2 high/critical risk subjects\n2. Resolve 1 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 42 missing data points\n5. Schedule reviews for 2 overdue visits\n"}
{"id": "study_Study 4", "study": "Study 4", "type": "study_summary", "total_subjects": 1328, "total_issues": 10736, "document": "# Study Summary: Study 4\n\n## Overview\n- **Total Subjects**: 1328\n- **Countries**: 19 (KOR, FRA, DEU, NLD, POL...)\n- **Sites**: 168\n- **Total Issues Identified**: 10736\n\n## Risk Distribution\n- **Low Risk**: 463 subjects (34.9%)\n- **Medium Risk**: 313 subjects (23.6%)\n- **High Risk**: 322 subjects (24.2%)\n- **Critical Risk**: 230 subjects (17.3%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 88\n- **Safety Discrepancies**: 10639\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 3\n- **Outstanding Visits**: 1\n\n## Pending Items\n- **Subjects with Pending Items**: 34 (2.6%)\n\n## Key Metrics\n- **Average Issues per Subject**: 8.08\n- **Clean Subjects (No Issues)**: 463 (34.9%)\n\n## Priority Subjects Requiring Attention\n- -\n- Subject 1002\n- Subject 1005\n- Subject 1006\n- Subject 1008\n- Subject 1009\n- Subject 1010\n- Subject 1014\n- Subject 1016\n- Subject 1018\n\n## CRA Recommendations\n1. Focus monitoring efforts on 552 high/critical risk subjects\n2. Resolve 88 open EDRR issues to improve data quality\n3. Address 10639 safety discrepancies as priority\n4. Follow up on 3 missing data points\n5. Schedule reviews for 1 overdue visits\n"}
{"id": "study_Study 5", "study": "Study 5", "type": "study_summary", "total_subjects": 639, "total_issues": 551, "document": "# Study Summary: Study 5\n\n## Overview\n- **Total Subjects**: 639\n- **Countries**: 23 (AUS, ARG, USA, JPN, SGP...)\n- **Sites**: 108\n- **Total Issues Identified**: 551\n\n## Risk Distribution\n- **Low Risk**: 540 subjects (84.5%)\n- **Medium Risk**: 62 subjects (9.7%)\n- **High Risk**: 33 subjects (5.2%)\n- **Critical Risk**: 4 subjects (0.6%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 5\n- **Safety Discrepancies**: 7\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 531\n- **Outstanding Visits**: 21\n\n## Pending Items\n- **Subjects with Pending Items**: 24 (3.8%)\n\n## Key Metrics\n- **Average Issues per Subject**: 0.86\n- **Clean Subjects (No Issues)**: 540 (84.5%)\n\n## Priority Subjects Requiring Attention\n- Subject 1690\n- Subject 1694\n- Subject 1724\n- Subject 1725\n- Subject 2242\n- Subject 2243\n- Subject 2245\n- Subject 2246\n- Subject 2336\n- Subject 2362\n\n## CRA Recommendations\n1. Focus monitoring efforts on 37 high/critical risk subjects\n2. Resolve 5 open EDRR issues to improve data quality\n3. Address 7 safety discrepancies as priority\n4. Follow up on 531 missing data points\n5. Schedule reviews for 21 overdue visits\n"}
{"id": "study_Study 6", "study": "Study 6", "type": "study_summary", "total_subjects": 52, "total_issues": 249, "document": "# Study Summary: Study 6\n\n## Overview\n- **Total Subjects**: 52\n- **Countries**: 7 (CHN, USA, JPN, AUS, SGP...)\n- **Sites**: 14\n- **Total Issues Identified**: 249\n\n## Risk Distribution\n- **Low Risk**: 35 subjects (67.3%)\n- **Medium Risk**: 13 subjects (25.0%)\n- **High Risk**: 1 subjects (1.9%)\n- **Critical Risk**: 3 subjects (5.8%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 0\n- **Safety Discrepancies**: 1\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 232\n- **Outstanding Visits**: 12\n\n## Pending Items\n- **Subjects with Pending Items**: 14 (26.9%)\n\n## Key Metrics\n- **Average Issues per Subject**: 4.79\n- **Clean Subjects (No Issues)**: 35 (67.3%)\n\n## Priority Subjects Requiring Attention\n- Subject 1513\n- Subject 1520\n- Subject 2586\n- Subject 39\n\n## CRA Recommendations\n1. Focus monitoring efforts on 4 high/critical risk subjects\n2. Resolve 0 open EDRR issues to improve data quality\n3. Address 1 safety discrepancies as priority\n4. Follow up on 232 missing data points\n5. Schedule reviews for 12 overdue visits\n"}
{"id": "study_Study 7", "study": "Study 7", "type": "study_summary", "total_subjects": 18, "total_issues": 751, "document": "# Study Summary: Study 7\n\n## Overview\n- **Total Subjects**: 18\n- **Countries**: 4 (TWN, SGP, CHN, JPN)\n- **Sites**: 7\n- **Total Issues Identified**: 751\n\n## Risk Distribution\n- **Low Risk**: 6 subjects (33.3%)\n- **Medium Risk**: 3 subjects (16.7%)\n- **High Risk**: 0 subjects (0.0%)\n- **Critical Risk**: 9 subjects (50.0%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 0\n- **Safety Discrepancies**: 5\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 733\n- **Outstanding Visits**: 0\n\n## Pending Items\n- **Subjects with Pending Items**: 6 (33.3%)\n\n## Key Metrics\n- **Average Issues per Subject**: 41.72\n- **Clean Subjects (No Issues)**: 6 (33.3%)\n\n## Priority Subjects Requiring Attention\n- Subject 25\n- Subject 26\n- Subject 27\n- Subject 28\n- Subject 2850\n- Subject 29\n- Subject 31\n- Subject 34\n- Subject 61\n\n## CRA Recommendations\n1. Focus monitoring efforts on 9 high/critical risk subjects\n2. Resolve 0 open EDRR issues to improve data quality\n3. Address 5 safety discrepancies as priority\n4. Follow up on 733 missing data points\n5. Schedule reviews for 0 overdue visits\n"}
{"id": "study_Study 8", "study": "Study 8", "type": "study_summary", "total_subjects": 599, "total_issues": 78, "document": "# Study Summary: Study 8\n\n## Overview\n- **Total Subjects**: 599\n- **Countries**: 24 (ARG, CAN, KOR, MYS, IND...)\n- **Sites**: 121\n- **Total Issues Identified**: 78\n\n## Risk Distribution\n- **Low Risk**: 563 subjects (94.0%)\n- **Medium Risk**: 33 subjects (5.5%)\n- **High Risk**: 3 subjects (0.5%)\n- **Critical Risk**: 0 subjects (0.0%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 16\n- **Safety Discrepancies**: 0\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 24\n- **Outstanding Visits**: 24\n\n## Pending Items\n- **Subjects with Pending Items**: 44 (7.3%)\n\n## Key Metrics\n- **Average Issues per Subject**: 0.13\n- **Clean Subjects (No Issues)**: 563 (94.0%)\n\n## Priority Subjects Requiring Attention\n- Subject 3172\n- Subject 3269\n- Subject 3331\n\n## CRA Recommendations\n1. Focus monitoring efforts on 3 high/critical risk subjects\n2. Resolve 16 open EDRR issues to improve data quality\n3. Address 0 safety discrepancies as priority\n4. Follow up on 24 missing data points\n5. Schedule reviews for 24 overdue visits\n"}
{"id": "study_Study 9", "study": "Study 9", "type": "study_summary", "total_subjects": 169, "total_issues": 33, "document": "# Study Summary: Study 9\n\n## Overview\n- **Total Subjects**: 169\n- **Countries**: 6 (BFA, GHA, KEN, GAB, UGA...)\n- **Sites**: 9\n- **Total Issues Identified**: 33\n\n## Risk Distribution\n- **Low Risk**: 164 subjects (97.0%)\n- **Medium Risk**: 1 subjects (0.6%)\n- **High Risk**: 4 subjects (2.4%)\n- **Critical Risk**: 0 subjects (0.0%)\n\n## Issue Breakdown\n- **Open EDRR Issues**: 0\n- **Safety Discrepancies**: 2\n- **Missing CRF Pages**: 0\n- **Missing Lab Records**: 31\n- **Outstanding Visits**: 0\n\n## Pending Items\n- **Subjects with Pending Items**: 0 (0.0%)\n\n## Key Metrics\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects (No Issues)**: 164 (97.0%)\n\n## Priority Subjects Requiring Attention\n- Subject 3407\n- Subject 3408\n- Subject 3409\n- Subject 3412\n\n## CRA Recommendations\n1. Focus monitoring efforts on 4 high/critical risk subjects\n2. Resolve 0 open EDRR issues to improve data quality\n3. Address 2 safety discrepancies as priority\n4. Follow up on 31 missing data points\n5. Schedule reviews for 0 overdue visits\n"}
